ItchAid - FranceMed Pharma

Message to our Valued Customers: Unfortunately ItchAid is sold out and we are currently out of stock as demand far exceeded supply. We are pleased to advise that we will be back in stock by 2nd week Jan 2021. Please check e-commerce sites from time to time. Thank you for your patience and custom and apologies for any inconvenience.

Veterinary Treatment
ItchAid® Mild to Severe Itching & topical pain in Pets e.g. Dogs, Horses and Cats - 150ml

ItchAid® Instant Itch and Pain Treatment Spray is a Patented, Unique, World's First, Pioneering, Topical, Micro-fine, Registered Medical Device Spray for the instant treatment of mild to severe Itching and pain due to Atopic Dermatitis, Skin Allergies, Insect Bites for all ages and during pregnancy. Clinically proven to instantly stop mild to severe itching, pain, stinging and achieve long lasting effect. The spray soothes inflamed and weeping skin. Free from steroids and antihistamines, Suitable for applying anywhere on the body, sensitive skin and to treat new born.
The spray employs the unique, patented, proprietary "Instant T-CNS Signalling System"™ delivery technology, clinically proven to work in seconds. No known side effects. Repetitive use over time, is clinically proven to treat the underlying condition.

Unique Product Attributes of ItchAid®

Instantly stops mild to severe itching due to Skin Allergies, Atopic Dermatitis, Sweet Itch and insect bites. Therefore the evidence of superfast efficacy is seconds away.
Calms red, sore, inflamed skin.
Covers large animal skin areas effortlessly within seconds.
Free from steroids and antihistamines.
No pills, no creams, no mess or fuss.
Treats a highly prevalent condition.
Drugs-free, safe for all ages and pregnant animals.
Clinically proven claims.
Long lasting effect, which may last for a few days.
Disruptive Technology.
Made in UK.

Click on the image to enlarge

var _gaq = _gaq || []; _gaq.push(['_setAccount', 'UA-7870337-1']); _gaq.push(['_setDomainName', 'none']); _gaq.push(['_setAllowLinker', true]); (function() { var ga = document.createElement('script'); ga.type = 'text/javascript'; ga.async = true; ga.src = ('https:' == document.location.protocol ? 'https://ssl' : 'http://www') + '.google-analytics.com/ga.js'; var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(ga, s); })(); _W.Analytics = _W.Analytics || {'trackers': {}}; _W.Analytics.trackers.wGA = '_gaq'; ;(function(p,l,o,w,i,n,g){if(!p[i]){p.GlobalSnowplowNamespace=p.GlobalSnowplowNamespace||[]; p.GlobalSnowplowNamespace.push(i);p[i]=function(){(p[i].q=p[i].q||[]).push(arguments) };p[i].q=p[i].q||[];n=l.createElement(o);g=l.getElementsByTagName(o)[0];n.async=1; n.src=w;g.parentNode.insertBefore(n,g)}}(window,document,'script','//cdn2.editmysite.com/js/wsnbn/snowday262.js','snowday')); var r = [99, 104, 101, 99, 107, 111, 117, 116, 46, 40, 119, 101, 101, 98, 108, 121, 124, 101, 100, 105, 116, 109, 121, 115, 105, 116, 101, 41, 46, 99, 111, 109]; var snPlObR = function(arr) { var s = ''; for (var i = 0 ; i < arr.length ; i++){ s = s + String.fromCharCode(arr[i]); } return s; }; var s = snPlObR(r); var regEx = new RegExp(s); _W.Analytics = _W.Analytics || {'trackers': {}}; _W.Analytics.trackers.wSP = 'snowday'; _W.Analytics.user_id = '23533560'; _W.Analytics.site_id = '831352365279194172'; // Setting do not track if the GDPR cookie is not present. This is then checked by the snowday initializer // to set tracking decisions. https://github.com/snowplow/snowplow-javascript-tracker/blob/2.6.2/src/js/tracker.js#L1509 window.doNotTrack = document.cookie.indexOf('gdpr-kb') === -1 ? 'yes' : null; var drSegmentsTag = document.getElementById('drSegments'); if (drSegmentsTag) { _W.Analytics.spContexts = _W.Analytics.spContexts || []; var segmentData = JSON.parse(drSegmentsTag.innerText); segmentData.forEach(function(test) { _W.Analytics.spContexts.push({ schema: "iglu:com.weebly/context_ab_segment/jsonschema/1-0-0", data: { test_id: test.name, segment: test.variant, } }); }); } (function(app_id, ec_hostname, discover_root_domain) { var track = window[_W.Analytics.trackers.wSP]; if (!track) return; track('newTracker', app_id, ec_hostname, { appId: app_id, post: true, platform: 'web', discoverRootDomain: discover_root_domain, cookieName: '_snow_', contexts: { webPage: true, performanceTiming: true, gaCookies: true }, crossDomainLinker: function (linkElement) { return regEx.test(linkElement.href); }, respectDoNotTrack: document.cookie.indexOf('gdpr-kb') === -1 }); track('trackPageView', _W.Analytics.user_id+':'+_W.Analytics.site_id, _W.Analytics.spContexts); track('crossDomainLinker', function (linkElement) { return regEx.test(linkElement.href); }); })( '_wn', 'ec.editmysite.com', true ); (function(jQuery) { try { if (jQuery) { jQuery('div.blog-social div.fb-like').attr('class', 'blog-social-item blog-fb-like'); var $commentFrame = jQuery('#commentArea iframe'); if ($commentFrame.length > 0) { var frameHeight = jQuery($commentFrame[0].contentWindow.document).height() + 50; $commentFrame.css('min-height', frameHeight + 'px'); } if (jQuery('.product-button').length > 0){ jQuery(document).ready(function(){ jQuery('.product-button').parent().each(function(index, product){ if(jQuery(product).attr('target') == 'paypal'){ if (!jQuery(product).find('> [name="bn"]').length){ jQuery('<input>').attr({ type: 'hidden', name: 'bn', value: 'DragAndDropBuil_SP_EC' }).appendTo(product); } } }); }); } } else { // Prototype $$('div.blog-social div.fb-like').each(function(div) { div.className = 'blog-social-item blog-fb-like'; }); $$('#commentArea iframe').each(function(iframe) { iframe.style.minHeight = '410px'; }); } } catch(ex) {} })(window._W && _W.jQuery); window._W.isEUUser = false; window._W.showCookieToAll = "";